Henry is a senior associate in the Intellectual Property group based in London.
Henry joined Bird & Bird in 2011 after completing his training contract with Herbert Smith LLP. He has a scientific background, graduating in 2005 with a Masters Degree in Chemistry from Oxford University.
Henry's practice is primarily focussed on patent litigation. He has assisted clients before the UK Patents Court and Court of Appeal as well as with the coordination of multi-jurisdictional patent litigation. Henry also regularly provides advice on intellectual property in the context of a range of commercial and corporate issues and has experience of trade mark, passing off and copyright matters. He has worked for clients from a number of different industries, including pharmaceutical, agricultural, aviation and chemicals. Due to his background, Henry has a particular interest in the life sciences sector.
Henry is also a case officer in the IPECs new IP Pro Bono scheme. He is one of four Bird & Bird IP Lawyers in the UK who have volunteered their services to help small businesses and individuals who are involved in an intellectual property dispute, providing support before the dispute becomes a court case. Henry regularly contributes to the CIPA Journal case reports.
The cases in which Henry has assisted include: CompactGTL Plc v Oxford Catalysts Group Plc (Fischer-Tropsch catalysis); Novartis v Teva (rivastigmine); Synthon v Tva (glatiramer acetate); Magnesium Elektron Ltd v Molycorp Chemicals and Oxides (Europe) Ltd (rare earth mixed oxides); Anan Kasei Co. Ltd & Anor v Molycorp Chemicals & Oxides (Europe) Ltd (cerium oxide).